Literature DB >> 8167509

Management of cutaneous T cell lymphoma.

E J Parry, R M Mackie.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8167509      PMCID： PMC2540005          DOI： 10.1136/bmj.308.6932.858b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Mycosis fungoides: time to define the best therapy.

Authors:  T M Kuzel; E Springer; H H Roenigk; S T Rosen
Journal:  J Natl Cancer Inst       Date:  1990-02-07       Impact factor: 13.506

2.  Cutaneous T cell lymphomas.

Authors:  P A Bunn
Journal:  BMJ       Date:  1994-02-26

3.  Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.

Authors:  T M Kuzel; K Gilyon; E Springer; D Variakojis; K Kaul; P A Bunn; L Evans; H H Roenigk; S T Rosen
Journal:  J Natl Cancer Inst       Date:  1990-02-07       Impact factor: 13.506

4.  [Combination therapy with interferon alfa 2a and PUVA in cutaneous T-cell lymphoma].

Authors:  H G Otte; A Herges; R Stadler
Journal:  Hautarzt       Date:  1992-11       Impact factor: 0.751

5.  Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.

Authors:  E N Mostow; S L Neckel; L Oberhelman; T F Anderson; K D Cooper
Journal:  Arch Dermatol       Date:  1993-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.